Otsuka

SMARTMEDICINE

Marketed for Otsuka
ponatinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XE24 - ponatinib : Belongs to the class of protein kinase inhibitors, other antineoplastic agents. Used in the treatment of cancer.

Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in